The global proton therapy market size was valued at USD 454.14 million in 2022 and is projected to grow at a 11.5% CAGR during the forecast period 2023 to 2029. The primary driver of the expansion of the global proton therapy market is the rising incidence of cancer worldwide. In addition, the increasing number of malignancies that can be treated with high radiation radiotherapy will accelerate the market's overall expansion. Protons also appear to disperse more petite than other x-ray radiation, ensuring less harm to the healthy tissues located close to the wound or the injured area. As a result, they are more popular nowadays, which will also push this market.

View Detailed Report Description Here -  

The global proton therapy market segmentation:
1) By Product Type: Systems, Software, Services
2) By Component: Proton Accelerator, Beam Transport System, Beam Delivery System, Nozzle, Image Viewers, Patient Positioning System (PPS)
3) By Type: Rotating Proton Therapy Systems, Non Rotating Proton Therapy Systems
4) Set-Up Systems: Multi-Room Systems, Compact/ Single-Room Systems
5) Application Type: Treatment Applications, Research Applications
6) End User: Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes

The single-room equipment segment is expected to account for a larger revenue share in the global proton therapy market, with a value share worldwide. It is projected to grow at a x% CAGR between 2022 and 2028. The main drivers behind the expansion of this market are probably rising hospital investments, expanding manufacturer-hospital relationships, and the low cost of this equipment. These systems also take less time and space to install and are relatively smaller in size. Additionally, the demand for single-room equipment is anticipated to increase during the projected period due to technological improvements. The market has recently seen an increase in single-room system regulatory approvals.

Request sample report at  

The Asia Pacific market is expected to increase in the global proton therapy market over the forecast period. It is projected to grow at a CAGR of 14% in the coming years.  The region's demand for proton therapy goods is projected to be driven by two primary factors: the rising occurrence of malignancies and a favorable reimbursement environment. Additionally, expanding hospital investments in opening new centers and rising consumer awareness of the benefits of this treatment method are anticipated to support market expansion throughout the projected period. Large numbers of cancer patients, increased hospitals and healthcare facilities, improved infrastructure, and inexpensive proton therapy costs are further reasons that are anticipated to fuel expansion. Due to their vast populations and significant unmet requirements, emerging countries like Singapore, China, and India are interested in many foreign investors.

Request Methodology:        

Key players’ profiles in the proton therapy market report are Ion Beam Applications, Provision Healthcare, Hitachi Ltd., Mevion Medical Systems, Optivus Proton Therapy Inc., Pronova Solutions LLC., Sumitomo Corporation, Siemens Ltd, Mirion Technologies, and Toshiba Corp.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: | D U N S® Number: 852781747